Lyme Vaccines Show New Promise, and Face Old Challenges
OCT 15, 2019 —
Please see today’s email below…..
Although Willyard’s article contains more truths than propaganda it is missing the detail outlined below.
Lyme Bumper Stickers (Public Service Announcement)
——— Original Message ———-
From: CARL TUTTLE <email@example.com>
To: firstname.lastname@example.org, email@example.com
Cc: (98 Undisclosed recipients)
Date: October 15, 2019 at 8:32 AM
Subject: Lyme Vaccines Show New Promise, and Face Old Challenges
Lyme Vaccines Show New Promise, and Face Old Challenges
Published October 07, 2019 By Cassandra Willyard
On October 14, 2019 Cassandra Willyard wrote:
“My editor at Undark pitched me the idea. I’ve written about it before.
Dear Ms. Willard,
Thank you for responding to my inquiry. I wanted to share the following references missing from your article and an email I sent to Dr. Stanley Plotkin who has previously published on the subject of Lyme disease vaccines. (Lemons and Lyme) I have carbon copied the Tick-Borne Disease Working Group.
I would like to point out the following case study from Stony Brook Lyme Clinic. I understand the patient received thirteen spinal taps, multiple courses of IV and oral meds, and relapsed after each one, proven by CSF antigens and/or PCR. The only way this patient (said to be a physician) remained in remission was to keep her on open ended clarithromycin– was on it for 22 months by the time of publication.
Seronegative Chronic Relapsing Neuroborreliosis.
Lawrence C.a · Lipton R.B.b · Lowy F.D.c · Coyle P.K.d
aDepartment of Medicine, bDepartment of Neurology, and cDivision of Infectious Diseases, Albert Einstein College of Medicine, and dDepartment of Neurology, State University of New York at Stony Brook, New York, NY., USA
Eur Neurol 1995; 35:113–117 (DOI:10.1159/000117104)
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
“In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of my patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. Her case made the front page of the New York Times Science Times in August of 1993.” – Kenneth Liegner, MD
Vicki Logan’s CDC Fort Collins Positive CSF Culture Report: (My personal Dropbox account)
Lyme patient Vicki Logan’s 1991 positive culture test performed by the Centers for Disease Control should have set off a red flag but was ignored while the focus remained on discrediting the sick and disabled Lyme patient population. 
Here are links to the seven page autopsy results of patient Vicki Logan showing histopathologic findings consistent with neurologic manifestations of chronic Lyme disease.
(Vicki Logan’s Autopsy results Page #1, 2, 3, 4, 5, 6, 7) My personal Dropbox storage area.
The destructive nature of Borrelia is evident in Vicki Logan’s liver (nutmeg liver), kidneys, heart, lungs and brain. The patient died (Medically Executed) after the insurer refused additional IV antibiotic therapy.
The following pilot study recently identified chronic Lyme disease in twelve patients from Canada. All of these patients were culture positive for infection (genital secretions, skin and blood) even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.
Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease
Article Published: 11 October 2019
The Long-Term Persistence of Borrelia burgdorferi Antigens and DNA in the Tissues of a Patient with Lyme Disease Eva Sapi 1,*, Rumanah S. Kasliwala 1 , Hebo Ismail 1 , Jason P. Torres 1 , Michael Oldakowski 1 , Sarah Markland 1 , Gauri Gaur 1 , Anthony Melillo 1 , Klaus Eisendle 2 , Kenneth B. Liegner 3,4,5 , Jenny Libien 6 and James E. Goldman 7
Conclusions: In summary, this study provides several lines of evidence that Borrelia can persist in the human body not only in the spirochetal but also in the antibiotic-resistant biofilm form, even after long-term antibiotic treatment. The presence of infiltrating lymphocytes in the vicinity of B. burgdorferi biofilms suggests that the biofilm might trigger chronic inflammatory responses.
Letter to Dr. Stanley Plotkin regarding the Lyme vaccine:
——— Original Message ———-
From: Carl Tuttle <firstname.lastname@example.org>
Cc: email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, JPIDS.EditorialOffice@oup.com
Date: September 19, 2018 at 9:48 AM
Subject: Lemons and Lyme by Stanley A. Plotkin
Journal of the Pediatric Infectious Diseases Society
13 September 2018 P L O T K I N C O L U M N
Lemons and Lyme
Stanley A. Plotkin
Emeritus Professor of Pediatrics, University of Pennsylvania, Doylestown
“It is odd that there is a lobby against the development and deployment of a vaccine against the disease by people who think they are suffering from Lyme infection in a chronic form, the existence of which remains doubtful. They believe that the first vaccine against Lyme disease caused chronic arthritis.”
Sept 19, 2018
Perelman School of Medicine
University of Pennsylvania
3400 Civic Center Boulevard
Building 421, Philadelphia, PA 19104
“It is odd” that the two principal investigators of the previous Lyme vaccines, Allen Steere for SmithKlineBeecham’s LymeRix and Gary Wormser for Connaught’s vaccine (which never made it to market) have been named in a racketeering lawsuit. (See attached court document)
It is believed that Lyme disease was pigeonholed into its current status by the two principal investigators of the previous Lyme disease vaccines as these investigators conceptualized a disease that would enable vaccine development.
A preventive vaccine for Lyme disease would not satisfy the FDA if a chronic persistent infection and seronegative disease exist. The lead author of the one-size-fits-all IDSA Lyme treatment guideline (which matches the conceptualized disease) was the principal investigator of Connaught’s Lyme vaccine, Dr. Gary Wormser. This is a flagrant conflict of interest. Have we been dealing with an antibiotic resistant/tolerant superbug purposely concealed to promote vaccine development?
Forty one years ago Allen Steere knew that antibiotics used to treat Lyme disease were not working:
Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.
“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”
A PubMed.gov search will find hundreds of papers reporting persistent Borrelia infection.
Summary to Cassandra Willyard:
For the past three decades, Lyme disease has been portrayed as hard to catch and easily treated  while those who control the narrative (Through editorial censorship) refuse to recognize this pathogen as an antibiotic resistant/tolerant superbug by suppressing evidence of persistent infection.  This misclassification has all but eliminated government funding that should have been equal to or greater than AIDS or Zika which are also life-altering/life-threatening infections in need of cures.
What we are dealing with here is an antibiotic resistant/tolerant superbug but the focus over the past three decades (as seen in the Lancet article) has been to discredit the sick and disabled along with the practitioners attempting to help these patients as opposed to finding new antimicrobials effective in eradicating all forms of the Borrelia spirochete; L-forms, round bodies and persister cells. [Biofilm forms]
The truth about this devastating disease has been kept from the public for 43 years and there are no Public Service Announcements informing the public that you could become horribly disabled or die from Lyme disease
A worldwide community of physicians has been influenced by the ongoing disinformation campaign aimed at promoting the idea that Lyme is little more than a nuisance disease as health agencies across the globe are blindly following what has been deceitfully established here in the U.S.
We are dealing with a life-altering/life-threatening infection with faulty/misleading antibody tests, inadequate treatment, no medical training and absolutely no disease control; a public health disaster.
This has been a 43 year epic failure on the part of the CDC and of course none of what I have presented here is found in your article.
You or a loved one is a single tick bite away from experiencing this travesty.
Lyme Endemic Hudson, NH
Cc: Editor in Chief TOM ZELLER JR.
1. Lyme disease antiscience
2. Lyme Disease Is Hard to Catch And Easy to Halt, Study Finds
New York Times By GINA KOLATA Published: June 13, 2001
Excerpt: But some who have treated hundreds of patients with long-term antibiotics, like Dr. Sam L. Donta of Boston University Medical Center, were not convinced. The antibiotics in the studies were not given for a long enough time, Dr. Donta said, and he would have chosen different ones. Perhaps all that the studies show, he said, is ”that this particular treatment doesn’t work.”
3. Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases after the mandated one-size-fits-all IDSA treatment approach: (700 articles)
If you haven’t signed Tuttle’s Petition calling for a Congressional investigation of the CDC, IDSA and ALDF, please do so here: https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf
Tuttle’s tireless advocacy is appreciated by all.
For more on the Lyme vaccine: https://madisonarealymesupportgroup.com/2018/07/01/lyme-vaccine-fail-safety-ignored/